Healthcare provider profile · identity verified

Barbara Laroque, M.D.

Internal Medicine · WESTERVILLE, OH · NPI 1255416889

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	558	162
Amlodipine Besylate	Amlodipine Besylate	511	156
Albuterol Sulfate Hfa	Albuterol Sulfate	364	103
Gabapentin	Gabapentin	282	65
Omeprazole	Omeprazole	245	63
Metformin Hcl	Metformin Hcl	215	63
Levothyroxine Sodium	Levothyroxine Sodium	208	48
Ozempic	Semaglutide	192	27
Lisinopril	Lisinopril	177	51
Losartan Potassium	Losartan Potassium	169	58
Trazodone Hcl	Trazodone Hcl	168	40
Famotidine	Famotidine	165	36
Hydrochlorothiazide	Hydrochlorothiazide	159	54
Trulicity	Dulaglutide	157	23
Metoprolol Succinate	Metoprolol Succinate	141	41
Tizanidine Hcl	Tizanidine Hcl	136	37
Carvedilol	Carvedilol	133	36
Furosemide	Furosemide	130	35
Metformin Hcl Er	Metformin Hcl	127	36
Fluticasone Propionate	Fluticasone Propionate	119	44
Rosuvastatin Calcium	Rosuvastatin Calcium	113	29
Montelukast Sodium	Montelukast Sodium	111	25
Ibuprofen	Ibuprofen	105	24
Metoprolol Tartrate	Metoprolol Tartrate	102	29
Pantoprazole Sodium	Pantoprazole Sodium	94	28
Ezetimibe	Ezetimibe	93	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	92	22
Jardiance	Empagliflozin	89	26
Pravastatin Sodium	Pravastatin Sodium	84	32
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	83	suppressed
Allopurinol	Allopurinol	79	25
Eliquis	Apixaban	76	23
Symbicort	Budesonide/Formoterol Fumarate	76	23
Sertraline Hcl	Sertraline Hcl	72	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	25
Meloxicam	Meloxicam	66	17
Nifedipine Er	Nifedipine	65	16
Clopidogrel	Clopidogrel Bisulfate	63	18
Tamsulosin Hcl	Tamsulosin Hcl	62	22
Duloxetine Hcl	Duloxetine Hcl	61	19
Incruse Ellipta	Umeclidinium Bromide	61	15
Triamcinolone Acetonide	Triamcinolone Acetonide	61	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	20
Zolpidem Tartrate	Zolpidem Tartrate	55	suppressed
Spironolactone	Spironolactone	51	19
Tradjenta	Linagliptin	48	11
Amitriptyline Hcl	Amitriptyline Hcl	47	12
Topiramate	Topiramate	46	suppressed
Breo Ellipta	Fluticasone/Vilanterol	45	suppressed
Potassium Chloride	Potassium Chloride	45	13
Diclofenac Sodium	Diclofenac Sodium	39	15
Hydroxyzine Hcl	Hydroxyzine Hcl	39	13
Ondansetron Hcl	Ondansetron Hcl	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	12
Simvastatin	Simvastatin	38	12
Celecoxib	Celecoxib	37	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	suppressed
Ventolin Hfa	Albuterol Sulfate	37	11
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Tramadol Hcl	Tramadol Hcl	35	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	34	suppressed
Fluconazole	Fluconazole	34	12
Glipizide Er	Glipizide	34	12
Farxiga	Dapagliflozin Propanediol	32	suppressed
Labetalol Hcl	Labetalol Hcl	32	suppressed
Prednisone	Prednisone	32	15
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Levemir Flexpen	Insulin Detemir	31	13
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Naproxen	Naproxen	30	11
Valsartan	Valsartan	29	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	28	16
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Promethazine Hcl	Promethazine Hcl	28	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	26	suppressed
Atrovent Hfa	Ipratropium Bromide	26	suppressed
Buspirone Hcl	Buspirone Hcl	26	14
Mirtazapine	Mirtazapine	26	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Ibu	Ibuprofen	25	suppressed
Cephalexin	Cephalexin	23	18
Levetiracetam	Levetiracetam	23	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Ammonium Lactate	Ammonium Lactate	22	suppressed
Clotrimazole	Clotrimazole	22	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Clonidine	Clonidine	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Cilostazol	Cilostazol	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Metronidazole	Metronidazole	17	suppressed
Nystatin	Nystatin	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	13
Synjardy	Empagliflozin/Metformin Hcl	16	suppressed
Baclofen	Baclofen	15	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	suppressed
Glipizide	Glipizide	14	suppressed
Gvoke Hypopen 2-Pack	Glucagon	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Linzess	Linaclotide	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Risperidone	Risperidone	13	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Irbesartan	Irbesartan	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error